Strategic Commercial Partner for Biotech and Life Sciences Companies in Europe

Auralis Biotech SRL is a strategic commercial partner for biotech, diagnostics and life sciences companies, headquartered in Italy and operating across Europe. We specialise in fractional business development consulting, EU market entry, partner matchmaking, and pharma intelligence strategy.

  • Who we are

    Auralis Biotech is a strategic commercial partner for biotech, diagnostics and life sciences companies across Europe. We work as an embedded extension of your team, from commercial positioning and market entry to strategic partnerships and exit preparation. Led by Giuseppina Sannino, PhD, with 10+ years of international experience in diagnostics, biopharma and molecular tools commercialization.

  • What we do

    We identify and close the commercial gaps that prevent scientific innovation from reaching its full value: from unclear positioning and missing market access, to strategic partner matching, EU market entry, and exit preparation on both sides of the transaction, for companies preparing to exit and for acquirers and investors sourcing European assets.

  • Who we work with

    • Growth-phase biotech and diagnostics companies ready to scale, partner or exit
    • Established life sciences organizations entering new European markets
    • Corporate acquirers and strategic investors sourcing European biotech assets
    • Non-EU manufacturers seeking a fractional commercial presence in Europe
    • Early-stage scientist-founders building their commercial foundations
1 of 3
  • Build

    Establish your commercial foundation

    • Commercial positioning and narrative (e.g. messaging framework, value proposition design)
    • Go-to-market strategy (e.g. market segmentation, channel mapping, launch planning)
    • Auralis LaunchPAD Master Course (e.g. live training, Sales and Mindset in Biotech)
    More about Build 
  • Grow

    Build traction and commercial momentum

    • Fractional business development (e.g. pipeline building, lead generation, outreach campaigns)
    • Scientific marketing and partner introductions (e.g. scientific content writing, SEO, GEO, LinkedIn authority)
    • Pharma Intelligence and Authority Strategy (e.g. competitive landscape, KOL mapping, thought leadership)
    More about Grow 
  • Scale

    Expand into Europe and beyond

    • EU market entry and distributor networks (e.g. distributor scouting, contract negotiation, regulatory pathway)
    • Fractional commercial arm (e.g. commercial strategy build-out, distributor network development, partner onboarding)
    • Strategic partner matching (e.g. partner profiling, strategic partner identification and outreach)
    More about Scale 
  • Exit

    Find your strategic partner or acquirer

    • Commercial narrative and data room preparation (e.g. science-to-value story, commercial documentation, portfolio positioning)
    • Strategic partner and acquirer identification (e.g. buyer scouting, technology scouting for corporates and funds)
    • Positioning for strategic acquisition or partnership (e.g. commercial readiness review, seller and buyer preparation)
    More about Exit 
1 of 4

How we work

Discovery Call - you share your science, goals, and challenges.
Assessment - we map your needs across strategy, marketing, partnerships, and commercial positioning.
Custom Plan - a tailored roadmap with milestones and deliverables.
Execution - we act as your commercial extension, delivering outreach, representation, and growth activities.
Ongoing Support - continuous advisory and matchmaking as your project evolves.

Book a discovery call

Assess your market readiness

Not sure which stage applies to you? Our free market readiness audit helps you understand your commercial position, identify gaps, and chart a clear path forward.

  • Trustech Diagnostics

    Italian deep-tech company developing EliChip, a portable immunodiagnostic platform, a field-ready alternative to traditional ELISA.

    Service:
    Fractional BD team: commercial strategy, go-to-market direction, investor and strategic partner identification, and scientific marketing.
    Stage: GROW

    Explore EliChip program 
  • BEE DIGITAL

    A full-service digital agency working in various industries, including Biopharma/Biotech.

    Service: Auralis acts as the embedded scientific layer, providing scientific accuracy, regulatory awareness, and audience relevance across website copywriting and scientifically grounded SEO and GEO, among other work.
    Stage: SCALE


  • M&A Boutique Advisory Collaboration

    Italian M&A boutique based in Turin working in various industries.

    Service: Auralis supports transactions involving biotech and medical technology companies. Our contribution covers commercial strategy, go-to-market direction, and strategic partner identification. Their team handles financial structuring and deal execution.

    Stage: SCALE

1 of 3
  • IN THE PRESS

    Published in Pharma Focus Asia (Issue 62, 2026). How point-of-need biotechnologies are redefining microbiological quality control in biopharma manufacturing.

    Read the article 
  • NEW PROGRAMME

    A 6-week live online programme for scientists building commercial confidence. Auralis LaunchPAD Master Course 2026. Pre-registration open now.

    Register interest 
  • OPEN CALL FOR DISTRIBUTORS

    Auralis Innovation Access Network
    For EU specialist distributors in biotech and diagnostics. Get privileged early access to pre-launch non-EU technologies before they reach open distribution. Free to join.

    Learn More 
1 of 3